Breaking News
More () »

MultiCare to launch COVID-19 vaccine booster trial in Spokane

The MultiCare Institute for Research and Innovation is looking for volunteers who received the Moderna vaccine to enroll in the trial.

SPOKANE, Wash. — The MultiCare Institute for Research and Innovation is looking for people who have received the Moderna vaccine to participate in a booster trial.

According to a press release from MultiCare, the institute is looking to enroll 200 adults in Spokane and Puget Sound. The participants must meet some requirements.

  • Are 18 years and older
  • Have received both doses of the Moderna COVID-19 vaccine at least six months prior to the trial
  • Have not received any previous vaccination for influenza in the previous six months, or any previous shingles vaccination other than the live, attenuated vaccine
  • Are not pregnant or planning to become pregnant within the next two months.

Dr. Jonathan Staben runs the trial at MultiCare and said that the study will take a look at both the positive and negative effects that using both vaccines will have on the volunteer.

"In this case, I think it helps just engender trust with the public that co-administering these vaccines together is a safe thing to do," Dr. Staben said. "This is an open label trial where the patients will know what they're getting."

The study will also take a look at the 50 microgram doses of the Moderna vaccine as opposed to the two earlier 100 microgram doses.

"It looks like the 50 microgram dose provides good boost in immunity and also has a good side effect balance," Dr. Staben said.

The trial is set to start Oct. 7, 2021.

To participate in the trial, email research@multicare.org or call (253) 403-7249.